A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.
Phase of Trial: Phase III
Latest Information Update: 27 Apr 2013
At a glance
- Drugs Tadalafil (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Eli Lilly
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register record: DRKS00004102).
- 21 Oct 2010 Last checked against ClinicalTrials.gov record.
- 18 Apr 2010 Results presented at the 25th Congress of the European Association of Urology.